The clinical effectiveness of carbapenem antibiotics such as meropenem is becoming increasingly compromised by the spread of both metallo-β-lactamase (MBL) and serine-β-lactamase (SBL) enzymes on mobile genetic elements, stimulating research to find new β-lactamase inhibitors to be used in conjunction with carbapenems and other β-lactam antibiotics. Herein, we describe our initial exploration of a novel chemical series of metallo-β-lactamase inhibitors, from concept to efficacy, in a survival model using an advanced tool compound (ANT431) in conjunction with meropenem.

Leiris, S., Coelho, A., Castandet, J., Bayet, M., Lozano, C., Bougnon, J., et al. (2019). SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model. ACS INFECTIOUS DISEASES, 5(1), 131-140 [10.1021/acsinfecdis.8b00246].

SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model

Benvenuti, Manuela;Pozzi, Cecilia;Mangani, Stefano;De Luca, Filomena;Docquier, Jean-Denis;
2019-01-01

Abstract

The clinical effectiveness of carbapenem antibiotics such as meropenem is becoming increasingly compromised by the spread of both metallo-β-lactamase (MBL) and serine-β-lactamase (SBL) enzymes on mobile genetic elements, stimulating research to find new β-lactamase inhibitors to be used in conjunction with carbapenems and other β-lactam antibiotics. Herein, we describe our initial exploration of a novel chemical series of metallo-β-lactamase inhibitors, from concept to efficacy, in a survival model using an advanced tool compound (ANT431) in conjunction with meropenem.
2019
Leiris, S., Coelho, A., Castandet, J., Bayet, M., Lozano, C., Bougnon, J., et al. (2019). SAR Studies Leading to the Identification of a Novel Series of Metallo-β-lactamase Inhibitors for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections That Display Efficacy in an Animal Infection Model. ACS INFECTIOUS DISEASES, 5(1), 131-140 [10.1021/acsinfecdis.8b00246].
File in questo prodotto:
File Dimensione Formato  
2019 ACS InfecDis VIM2.pdf

accesso aperto

Tipologia: PDF editoriale
Licenza: Creative commons
Dimensione 6.49 MB
Formato Adobe PDF
6.49 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1071869